Christopher C. Caillouet

Array ( [id] => 5259731 [patent_doc_number] => 20070213363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Tetrahydro-Quinolinylurea Derivatives' [patent_app_type] => utility [patent_app_number] => 10/578413 [patent_app_country] => US [patent_app_date] => 2004-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15216 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213363.pdf [firstpage_image] =>[orig_patent_app_number] => 10578413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145672 [patent_doc_number] => 20050119268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Treatment of CRTH2-mediated diseases and conditions' [patent_app_type] => utility [patent_app_number] => 10/972060 [patent_app_country] => US [patent_app_date] => 2004-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9896 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119268.pdf [firstpage_image] =>[orig_patent_app_number] => 10972060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 630581 [patent_doc_number] => 07132542 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-07 [patent_title] => 'Compounds for the treatment of male erectile dysfunction' [patent_app_type] => utility [patent_app_number] => 10/964080 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7712 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/132/07132542.pdf [firstpage_image] =>[orig_patent_app_number] => 10964080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 533210 [patent_doc_number] => 07179920 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-20 [patent_title] => '3-thia-4-arylquinolin-2-one derivatives' [patent_app_type] => utility [patent_app_number] => 10/964489 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9376 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/179/07179920.pdf [firstpage_image] =>[orig_patent_app_number] => 10964489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7238167 [patent_doc_number] => 20050080079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => '3-Thia-4-arylquinolin-2-one derivatives' [patent_app_type] => utility [patent_app_number] => 10/963889 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6546 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080079.pdf [firstpage_image] =>[orig_patent_app_number] => 10963889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609782 [patent_doc_number] => 07151180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-19 [patent_title] => 'Potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 10/963890 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7916 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/151/07151180.pdf [firstpage_image] =>[orig_patent_app_number] => 10963890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5716189 [patent_doc_number] => 20060079552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => '1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea salt' [patent_app_type] => utility [patent_app_number] => 10/962960 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4635 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20060079552.pdf [firstpage_image] =>[orig_patent_app_number] => 10962960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 281853 [patent_doc_number] => 07553853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Solid-state montelukast' [patent_app_type] => utility [patent_app_number] => 10/960639 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6871 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/553/07553853.pdf [firstpage_image] =>[orig_patent_app_number] => 10960639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584445 [patent_doc_number] => 07449582 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => 'Compounds and compositions as protein kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/961646 [patent_app_country] => US [patent_app_date] => 2004-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23251 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449582.pdf [firstpage_image] =>[orig_patent_app_number] => 10961646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 463830 [patent_doc_number] => 07238707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Substituted pentanols, a process for their production and their use as anti-inflammatory agents' [patent_app_type] => utility [patent_app_number] => 10/957742 [patent_app_country] => US [patent_app_date] => 2004-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5837 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238707.pdf [firstpage_image] =>[orig_patent_app_number] => 10957742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083895 [patent_doc_number] => 20050049275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Racemization and enantiomer separation of clopidogrel' [patent_app_type] => utility [patent_app_number] => 10/958072 [patent_app_country] => US [patent_app_date] => 2004-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7185 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049275.pdf [firstpage_image] =>[orig_patent_app_number] => 10958072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478895 [patent_doc_number] => 07223761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Salts and polymorphs of a potent antidiabetic compound' [patent_app_type] => utility [patent_app_number] => 10/956251 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 14259 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223761.pdf [firstpage_image] =>[orig_patent_app_number] => 10956251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5142558 [patent_doc_number] => 20070004774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Cept inhibitors and metabolites thereof' [patent_app_type] => utility [patent_app_number] => 10/579898 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11324 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004774.pdf [firstpage_image] =>[orig_patent_app_number] => 10579898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117272 [patent_doc_number] => 20050070573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Aminoquinoline compounds' [patent_app_type] => utility [patent_app_number] => 10/953937 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6617 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070573.pdf [firstpage_image] =>[orig_patent_app_number] => 10953937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105253 [patent_doc_number] => 20050107372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => '2-(Quinolonyl)-fused heterocycles as androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 10/953988 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8680 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107372.pdf [firstpage_image] =>[orig_patent_app_number] => 10953988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664283 [patent_doc_number] => 20080255190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => '8-Cyanoquinolonecarboxylic Acid Derivative' [patent_app_type] => utility [patent_app_number] => 10/572742 [patent_app_country] => US [patent_app_date] => 2004-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9463 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255190.pdf [firstpage_image] =>[orig_patent_app_number] => 10572742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070324 [patent_doc_number] => 20070191426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation' [patent_app_type] => utility [patent_app_number] => 10/572913 [patent_app_country] => US [patent_app_date] => 2004-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13909 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191426.pdf [firstpage_image] =>[orig_patent_app_number] => 10572913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7117273 [patent_doc_number] => 20050070574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-31 [patent_title] => 'Novel compounds' [patent_app_type] => utility [patent_app_number] => 10/949185 [patent_app_country] => US [patent_app_date] => 2004-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19795 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20050070574.pdf [firstpage_image] =>[orig_patent_app_number] => 10949185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916283 [patent_doc_number] => 20080096884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => '4-Aminoquinoline-3-Carboxamide Derivatives as Pde4 Inhibitors' [patent_app_type] => utility [patent_app_number] => 10/572914 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13886 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096884.pdf [firstpage_image] =>[orig_patent_app_number] => 10572914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7145825 [patent_doc_number] => 20050119296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Substituted heteroaryl benzofuran acids' [patent_app_type] => utility [patent_app_number] => 10/947840 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15603 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20050119296.pdf [firstpage_image] =>[orig_patent_app_number] => 10947840 [rel_patent_id] =>[rel_patent_doc_number] =>)